论文部分内容阅读
由中华医学会杂志社和军事医学科学院生物工程研究所联合举办的重组人白细胞介素2临床应用研讨会,于1996年9月17～20日在北京召开,来自北京等十多个省、市的100多位代表出席会议,国家卫生部有关领导到会做了指示。 会议上,北京中日友好医院赵武述教授结合临床对白介素2(IL-2)的作用机理作了详细的介绍,中国医学科学院肿瘤医院储大同教授对IL-2应用的历史、进展,前景进行了概述,卫生部药审
The Symposium on Clinical Application of Recombinant Human Interleukin 2 Co-organized by the Chinese Medical Association and the Institute of Biomedical Engineering, Academy of Military Medical Sciences was held in Beijing from September 17 to September 20, 1996. It was attended by more than 10 provinces and municipalities including Beijing More than 100 representatives attended the meeting and relevant leaders of the Ministry of Health of the People’s Republic of China made an instruction. At the meeting, Professor Wu-Shu Zhao from Beijing Sino-Japanese Friendship Hospital made a detailed introduction of the mechanism of action on interleukin-2 (IL-2). Professor Datong Datong, Cancer Hospital of Chinese Academy of Medical Sciences, reviewed the history, progress and prospect of IL-2 application The overview, the Ministry of Health drug trial